“…In effort to confer additional G4 selectivity to Ru-TAP complexes, the Elias group conjugated a known G4 binding chemotype, chlorophenylimizdazophenanthroline (CPIP), to the Ru-TAP center (52-55, Figure 23). [81] Several approaches to introduce the TAP functionality were pursued, including by modifying the CPIP ligand itself to include the pyrazine functionality (53), by employing TAP ancillary ligands (54), or by combination of both strategies (55). The control ligand (52), containing only phenanthroline ligands and no TAP functionality, did not promote oxidation, observed as an increase in ligand luminescence on DNA binding (indicating the excited state is not quenched by an oxidative process).…”